Repurposing the selective estrogen receptor modulator bazedoxifene to suppress gastrointestinal cancer growth
Abstract Excessive signaling through gp130, the shared receptor for the interleukin (IL)6 family of cytokines, is a common hallmark in solid malignancies and promotes their progression. Here, we established the in vivo utility of bazedoxifene, a steroid analog clinically approved for the treatment o...
| الحاوية / القاعدة: | EMBO Molecular Medicine |
|---|---|
| المؤلفون الرئيسيون: | , , , , , , , , , , , , , , , , , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
Springer Nature
2019-03-01
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://doi.org/10.15252/emmm.201809539 |
